ArticleBioinformatics (Oxford, England)2026
CoMBCR: Co-Learning Multi-Modalities of BCRs and gene expressions.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
motivationB-cell receptors (BCRs) and gene expression profiles are two distinct yet complementary modalities of B cells. However, most analyses treat them independently. Here, we present CoMBCR, a B-cell embedding tool that co-learns BCRs and gene expressions, representing data within a unified latent space for downstream analysis.
resultsWe applied CoMBCR to 126,791 B cells from diverse datasets with matched BCRs and gene expressions. First, CoMBCR outperforms the methods solely encoding BCRs in capturing B-cell biological features, achieving at least 0.1 improvement in Matthews Correlation Coefficient on a SARS-CoV-2 binding prediction task. Second, CoMBCR reveals active immune responses and CDR3 motif preferences through modality gap analysis in SARS-CoV-2-specific memory B cells. Moreover, when supported by spatial transcriptomics data, CoMBCR accurately traces the developmental trajectories of malignant B cells and uncovers transcriptional patterns associated with their survival within lymphoma patients. AVAILABILITY AND IMPLEMENTATION: The CoMBCR software is publicly available under the MIT License at https://github.com/deepomicslab/CoMBCR.git. CONTACT: shuaicli@cityu.edu.hk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.